Literature DB >> 16611715

Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.

Areef Ishani1, Greg A Grandits, Richard H Grimm, Kenneth H Svendsen, Allan J Collins, Ronald J Prineas, James D Neaton.   

Abstract

The incidence of ESRD is increasing rapidly. Limited information exists regarding early markers for the development of ESRD. This study aimed to determine over 25 yr the risk for ESRD associated with proteinuria, estimated GFR (eGFR), and hematocrit in men who did not have identified kidney disease and were randomly assigned into the Multiple Risk Factor Intervention Study (MRFIT). A total of 12,866 men who were at high risk for heart disease were enrolled (1973 to 1975) and followed through 1999. Renal replacement therapy was ascertained by matching identifiers with the United States Renal Data System's data; vital status was from the National Death Index. Men who initiated renal replacement therapy or died as a result of kidney disease were deemed to have developed ESRD. Dipstick urine for proteinuria, eGFR, and hematocrit were related to development of ESRD. During 25 yr, 213 (1.7%) men developed ESRD. Predictors of ESRD were dipstick proteinuria of 1+ or > or =2+ (hazard ratio [HR] 3.1 [95% confidence interval (CI) 1.8 to 5.4] and 15.7 [95% CI 10.3 to 23.9] respectively) and an eGFR of <60 ml/min per 1.73 m(2) (HR 2.4; 95% CI 1.5 to 3.8). Correlation between eGFR and serum creatinine was 0.9; the risk for ESRD with a 1-SD difference of each was identical (HR 1.21). Bivariate analysis demonstrated a 41-fold increase in ESRD risk in those with an eGFR <60 ml/min per 1.73 m(2) and > or =2+ proteinuria (95% CI 15.2 to 71.1). There was no association between hematocrit and ESRD. Other baseline measures that independently predicted ESRD included age, cigarette smoking, BP, low HDL cholesterol, and fasting glucose. Among middle-aged men who were at high risk for cardiovascular disease but had no clinical evidence of cardiovascular disease or significant kidney disease, dipstick proteinuria and an eGFR value <60 ml/min per 1.73 m(2) were strong predictors of long-term development of ESRD. It remains unknown whether intervention for proteinuria or early identification of those with chronic kidney disease reduces the risk for ESRD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611715     DOI: 10.1681/ASN.2005091012

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  94 in total

1.  Race disparities in U.S. nephrology fellowship training.

Authors:  Chavon Onumah; Paul L Kimmel; Mark E Rosenberg
Journal:  Clin J Am Soc Nephrol       Date:  2011-01-27       Impact factor: 8.237

2.  Nicotine, smoking, podocytes, and diabetic nephropathy.

Authors:  Edgar A Jaimes; Ming-Sheng Zhou; Mohammed Siddiqui; Gabriel Rezonzew; Runxia Tian; Surya V Seshan; Alecia N Muwonge; Nicholas J Wong; Evren U Azeloglu; Alessia Fornoni; Sandra Merscher; Leopoldo Raij
Journal:  Am J Physiol Renal Physiol       Date:  2021-01-18

3.  Racial and ethnic differences in albuminuria in individuals with estimated GFR greater than 60 mL/min/1.73 m(2): results from the Kidney Early Evaluation Program (KEEP).

Authors:  Stacey E Jolly; Nilka Ríos Burrows; Shu-Cheng Chen; Suying Li; Claudine T Jurkovitz; Andrew S Narva; Keith C Norris; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2010-03       Impact factor: 8.860

4.  Applying the Temporal Abstraction Technique to the Prediction of Chronic Kidney Disease Progression.

Authors:  Li-Chen Cheng; Ya-Han Hu; Shr-Han Chiou
Journal:  J Med Syst       Date:  2017-04-11       Impact factor: 4.460

5.  Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.

Authors:  Ron T Gansevoort; Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh
Journal:  Kidney Int       Date:  2011-02-02       Impact factor: 10.612

6.  Variability in Total Cholesterol Is Associated With the Risk of End-Stage Renal Disease: A Nationwide Population-Based Study.

Authors:  Mee Kyoung Kim; Kyungdo Han; Eun Sil Koh; Hun-Sung Kim; Hyuk-Sang Kwon; Yong-Moon Park; Kun-Ho Yoon; Seung-Hwan Lee
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-08-31       Impact factor: 8.311

7.  Population-based screening for CKD.

Authors:  Neil R Powe; L Ebony Boulware
Journal:  Am J Kidney Dis       Date:  2009-03       Impact factor: 8.860

8.  Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly.

Authors:  Dena E Rifkin; Ronit Katz; Michel Chonchol; Linda F Fried; Jie Cao; Ian H de Boer; David S Siscovick; Michael G Shlipak; Mark J Sarnak
Journal:  Nephrol Dial Transplant       Date:  2009-12-15       Impact factor: 5.992

9.  Early detection of chronic kidney disease: results of the PolNef study.

Authors:  Ewa Król; Bolesław Rutkowski; Piotr Czarniak; Ewa Kraszewska; Sławomir Lizakowski; Radosław Szubert; Stanisław Czekalski; Władysław Sułowicz; Andrzej Wiecek
Journal:  Am J Nephrol       Date:  2008-09-23       Impact factor: 3.754

10.  Screening for CKD with eGFR: doubts and dangers.

Authors:  Richard J Glassock; Christopher Winearls
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.